companies / o11-biomedical-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-06-07 json
| total_raised | 2,700,0002.7M | ○ |
|---|---|---|
| founded | 2022 | |
| hq | DE | |
| industry | unknown | |
| stage | null |
Enteral CO2 absorption therapy (RESPILIQ) for hypercapnic lung failure — EIC Accelerator
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-02-01 | grant | 2,700,0002.7M | null | ○ |
friendly-challenge, jquery, mywebsite, mywebsite creator, nginx, parallax.js, php
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |